These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 33035545

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Amorphous nano morin outperforms native molecule in anticancer activity and oral bioavailability.
    Jangid AK, Agraval H, Gupta N, Jain P, Yadav UCS, Pooja D, Kulhari H.
    Drug Dev Ind Pharm; 2020 Jul; 46(7):1123-1132. PubMed ID: 32469607
    [Abstract] [Full Text] [Related]

  • 3. Designing of fatty acid-surfactant conjugate based nanomicelles of morin hydrate for simultaneously enhancing anticancer activity and oral bioavailability.
    Jangid AK, Agraval H, Gupta N, Yadav UCS, Sistla R, Pooja D, Kulhari H.
    Colloids Surf B Biointerfaces; 2019 Mar 01; 175():202-211. PubMed ID: 30530006
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
    Bhatt H, Rompicharla SVK, Komanduri N, Aashma S, Paradkar S, Ghosh B, Biswas S.
    Curr Drug Deliv; 2018 Mar 01; 15(9):1271-1283. PubMed ID: 29732970
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhanced oral bioavailability and anticancer efficacy of fisetin by encapsulating as inclusion complex with HPβCD in polymeric nanoparticles.
    Kadari A, Gudem S, Kulhari H, Bhandi MM, Borkar RM, Kolapalli VR, Sistla R.
    Drug Deliv; 2017 Nov 01; 24(1):224-232. PubMed ID: 28156161
    [Abstract] [Full Text] [Related]

  • 10. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
    Sun J, Bi C, Chan HM, Sun S, Zhang Q, Zheng Y.
    Colloids Surf B Biointerfaces; 2013 Nov 01; 111():367-75. PubMed ID: 23856543
    [Abstract] [Full Text] [Related]

  • 11. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake.
    Baek JS, Cho CW.
    Eur J Pharm Biopharm; 2017 Aug 01; 117():132-140. PubMed ID: 28412471
    [Abstract] [Full Text] [Related]

  • 12. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
    Doktorovova S, Souto EB, Silva AM.
    Pharm Dev Technol; 2018 Jan 01; 23(1):96-105. PubMed ID: 28949267
    [Abstract] [Full Text] [Related]

  • 13. Solid lipid nanoparticles of anticancer drug andrographolide: formulation, in vitro and in vivo studies.
    Parveen R, Ahmad FJ, Iqbal Z, Samim M, Ahmad S.
    Drug Dev Ind Pharm; 2014 Sep 01; 40(9):1206-12. PubMed ID: 23826860
    [Abstract] [Full Text] [Related]

  • 14. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines.
    Ahmed MM, Fatima F, Anwer MK, Aldawsari MF, Alsaidan YSM, Alfaiz SA, Haque A, Az A, Alhazzani K.
    Chem Phys Lipids; 2020 Nov 01; 233():105003. PubMed ID: 33096096
    [Abstract] [Full Text] [Related]

  • 15. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P, Yu T, Liu Y, Jiang J, Xu J, Zhao Y, Hao Y, Qiu Y, Zhao W, Wu C.
    Drug Des Devel Ther; 2016 Nov 01; 10():911-25. PubMed ID: 27041995
    [Abstract] [Full Text] [Related]

  • 16. Baicalin encapsulating lipid-surfactant conjugate based nanomicelles: Preparation, characterization and anticancer activity.
    Jangid AK, Agraval H, Rai DB, Jain P, Yadav UC, Pooja D, Kulhari H.
    Chem Phys Lipids; 2020 Nov 01; 233():104978. PubMed ID: 32991905
    [Abstract] [Full Text] [Related]

  • 17. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N, Veerabrahma K.
    Drug Deliv; 2016 Nov 01; 23(2):395-404. PubMed ID: 24865287
    [Abstract] [Full Text] [Related]

  • 18. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
    Wang S, Chen T, Chen R, Hu Y, Chen M, Wang Y.
    Int J Pharm; 2012 Jul 01; 430(1-2):238-46. PubMed ID: 22465546
    [Abstract] [Full Text] [Related]

  • 19. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.
    Zhang S, Wang J, Pan J.
    Drug Deliv; 2016 Nov 01; 23(9):3696-3703. PubMed ID: 27749105
    [Abstract] [Full Text] [Related]

  • 20. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles.
    Jang DJ, Moon C, Oh E.
    Biomed Pharmacother; 2016 May 01; 80():162-172. PubMed ID: 27133053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.